fls.txt



item1.txt
Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems.
Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation industries.
Unless otherwise indicated, references to AstroNova, the Company, we, our, and us in this Quarterly Report on Form 10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein.
Certain amounts in the prior year financial statements have been reclassified to conform to the current years presentation.
The accounting polices used in preparing the condensed consolidated financial statements in this Form 10-Q are the same as those used in preparing the Consolidated Financial Statements for the year ended January 31, 2019, except for the change resulting from the adoption of Accounting Standard Codification Topic 842 (ASC 842), Leases.
We derive revenue from the sale of (i) hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems and airborne printers used in the flight deck and cabin of military, commercial and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.
We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time.
The Company recognized $279,000 of revenue during the nine month period ended November 2, 2019, related to the deferred revenue balance at January 31, 2019.
These costs are deferred and amortized based on the forecasted number of units sold over the estimated benefit term, which was estimated to be approximately 10 years.
The Company amortized $82,000 of direct costs for the nine months ended November 2, 2019 and the balance of deferred incremental direct costs net of accumulated amortization at November 2, 2019 was $942,000, of which $117,000 is reported in other current assets and $825,000 is reported in other assets in the accompanying condensed consolidated balance sheet.
For the three and nine months ended November 2, 2019, the diluted per share amounts do not reflect common equivalent shares outstanding of 238,477 and 206,592, respectively.
For the three and nine months ended October 27, 2018, the diluted per share amounts do not reflect common equivalent shares outstanding of 228,600 and 333,175, respectively.
With respect to the acquired intangibles included in the table above, amortization expense of $1.1 million and $1.0 million has been included in the condensed consolidated statements of income for the three months ended November 2, 2019 and October 27, 2018, respectively.
Amortization expense of $3.2 million and $3.1 million related to the above acquired intangibles has been included in the condensed consolidated statement of income for the nine months ended November 2, 2019 and October 27, 2018, respectively.
Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner.
Amounts borrowed under the revolving credit facility bear interest at a rate per annum equal to, at the Companys option, either (a) the LIBOR rate (or, in the case of revolving credit loans denominated in a currency other than U.S.
Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.0% to 1.5% based on the Companys consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal funds rate plus 0.50%, (ii) Bank of Americas publicly announced prime rate or (iii) the LIBOR rate plus 1.00%, plus a margin that varies within a range of 0.0% to 0.5% based on the Companys consolidated leverage ratio.


item4.txt



